Figure 2From: Low Annexin A1 expression predicts benefit from induction chemotherapy in oral cancer patients with moderate or poor pathologic differentiation grade Overall survival, disease-free survival, locoregional recurrence-free survival, distant metastasis-free survival in the patients with low and high Annexin A1 expression. A trend of low Annexin A1 expression indicating a better overall survival (A) and distant metastasis-free survival (D) compared to high Annexin A1 expression; however, a low Annexin A1 expression significantly indicating a better disease-free survival (B) and locoregional recurrence-free survival (C) compared to high Annexin A1 expression.Back to article page